IP Library › Assignment 037553/0678
Patent Assignment
Reel/Frame 037553/0678

Change of Name

Recorded: 2016-01-19 Pages: 5
Assignor
THERACOAT LTD.
Executed: 2015-11-09
Assignee
UROGEN PHARMA LTD.
13 HASADNA STREET, P.O. BOX 2397, RAANANA, 43650, ISRAEL
Covered Properties (6)
Material and Method for Treating Internal Cavities
Patent: 9,040,074 →
Application: 13/553,198 →
Publication: US 2013/0046275
Methods for Treatment of Bladder Cancer
Patent: 9,011,411 →
Application: 13/726,162 →
Publication: US 2013/0110030
Biocompatible Drug Delivery Apparatus and Methods
Patent: 8,936,566 →
Application: 13/726,165 →
Publication: US 2013/0110031
Material and Method for Treating Internal Cavities
Application: 14/054,731 →
Publication: US 2014/0105884
Production of Thermoreversible Hydrogels for Therapeutic Applications
Application: 14/233,770 →
Publication: US 2014/0142191
Slow Release Formulations of Cell Cycle Regulators and Anti-Cancer Agents for Local Treatment of Solid Cancer
Patent: 9,801,854 →
Application: 14/600,354 →
Related Assignments (11)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 5, 2012
From: HOLZER, ASHER; DANIEL, DORIT; MULLERAD, MICHAEL; DE LA ZERDA, JAIME
To: THERACOAT LTD.
Reel/Frame 029238/0909 →
Assignment of Assignor's Interest Jun 13, 2013
From: HOLZER, ASHER; DANIEL, DORIT; HIRSZOWICZ, ERAN
To: THERACOAT LTD.
Reel/Frame 030605/0477 →
Assignment of Assignor's Interest Jan 9, 2014
From: KONORTY, MARINA; HAKIM, GIL
To: THERACOAT LTD
Reel/Frame 031947/0586 →
Assignment of Assignor's Interest Jan 21, 2014
From: DE LA ZERDA, JAIME; DOLLBERG, YOSH; SHPOLANSKY, URI; MALCHI, NADAV
To: THERACOAT LTD.
Reel/Frame 032094/0219 →
Security Interest Apr 8, 2021
From: UROGEN PHARMA LTD.
To: RTW INVESTMENTS ICAV
Reel/Frame 055868/0385 →
Security Interest Mar 18, 2022
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC
Reel/Frame 059302/0501 →
Amended and Restated Patent Security Agreement May 19, 2022
From: UROGEN PHARMA LTD.
To: RTW INVESTMENTS ICA V
Reel/Frame 060121/0591 →
Patent Security Agreement Mar 18, 2024
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC
Reel/Frame 066805/0346 →
Amended and Restated Patent Security Agreement Mar 6, 2025
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC [COLLATERAL AGENT]
Reel/Frame 070434/0319 →
Amended and Restated Patent Security Agreement Aug 18, 2025
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 072472/0233 →
Second Amended and Restated Patent Security Agreement Mar 2, 2026
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 074994/0338 →